ECHO (Epidemiology of Cancer Healthcare & Outcomes)
The ECHO research group is a multi-disciplinary team established in 2015. We contribute to global efforts to control the increasing burden of neoplastic disease through research.
Our research spans the examination of:
Diagnostic intervals and pathways
Potentially avoidable delays in the diagnosis of symptomatic patients with underlying (as-yet-undiagnosed) cancer, and the understanding of responsible mechanisms
Prodromal symptoms of cancer
Understanding the predictive value of presenting symptoms and tests for cancer and other consequential illness in patients consulting in primary care
Variation in cancer health care
Analysing differences in cancer diagnosis and treatment between patients and healthcare organisations, in England and other countries, to target interventions.
Follow the links below to find out more about us:
-
Click to view image at full size and access the gallery slider.
See where our research has been used to guide policy
-
Click to view image at full size and access the gallery slider.
Find out more about our PPIE activities
-
Click to view image at full size and access the gallery slider.
Read more about what we've been up to
-
Click to view image at full size and access the gallery slider.
Find out who we are as a research unit.
See where our research has been used to guide policy
Find out more about our PPIE activities
Read more about what we've been up to
Find out who we are as a research unit.
We collaborate with colleagues at the University of Cambridge, the University of Exeter, the University of Leicester, the London School of Hygiene & Tropical Medicine, The University of Melbourne, The University of Oxford, and the University of Surrey.
Our work is chiefly supported by research grants or studentships by Cancer Research UK, the National Institute for Health Research, and Health Data Research UK.